Related Experiment Video

Updated: Jan 28, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

9.2K

Mitogen-Activated Protein Kinase (MAPK): New Insights in Breast Cancer

Huanyu Lu1, Yue Guo1, Gaurav Gupta2

  • 1Shandong University, Cheeloo College of Medicine, Jinan, Shandong Province, 250012, China.

Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer
|February 27, 2019
PubMed

Insights

The mitogen-activated protein kinase (MAPK) pathway is crucial for anticancer therapy and cancer development, particularly in breast cancer. Further research into novel drugs targeting this pathway is essential for effective treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The mitogen-activated protein kinase (MAPK) pathway is a key signaling cascade involved in eukaryotic cell cycle regulation.
  • The Ras/Raf/MEK/ERK pathway, a component of the MAPK cascade, plays a critical role in cell survival and cancer development, notably in breast cancer.

Purpose of the Study:

  • To review current anticancer treatments targeting the MAPK pathway.
  • To provide novel insights into the therapeutic potential of targeting the MAPK signaling cascade.
  • To highlight the need for investigating new drugs and clinical trials considering genetic defects in tumor genesis.

Main Methods:

  • Literature review of existing studies on the MAPK pathway in cancer.
  • Analysis of genetic defects associated with tumor genesis in specific populations.
  • Synthesis of current knowledge on MAPK pathway-targeted anticancer therapies.

Main Results:

  • The MAPK pathway is a significant target for anticancer drug development.
  • Genetic variations influence tumor development and response to therapy.
  • Current research is exploring novel therapeutic strategies within the MAPK signaling cascade.

Conclusions:

  • The MAPK pathway represents a promising target for developing novel anticancer therapies.
  • Understanding the genetic basis of cancer is crucial for personalized treatment approaches.
  • Continued investigation into MAPK pathway inhibitors and clinical trials is warranted for effective breast cancer treatment.

More Related Videos

Assaying Protein Kinase Activity with Radiolabeled ATP08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

19.3K
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.8K

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.2K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.4K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.4K